Skip to main content
CNSP logo

CNSP · CNS Pharmaceuticals, Inc.

$5.23 -0.18 (-3.33%) At close · Jul 24
Market Cap
$7.64M
Shares
1.46M

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-07-24 1,247 0 4,522 27.6%
2026-07-23 462 0 4,430 10.4%
2026-07-22 1,722 967 4,340 39.7%
2026-07-21 953 0 10,177 9.4%
2026-07-20 3,682 0 8,293 44.4%
2026-07-17 1,153 0 4,555 25.3%
2026-07-16 1,859 6 4,861 38.2%
2026-07-15 594 0 2,125 28.0%
2026-07-14 1,201 0 2,597 46.2%
2026-07-13 1,039 0 2,095 49.6%
2026-07-10 889 0 2,890 30.8%
2026-07-09 4,702 0 6,290 74.8%
2026-07-08 2,863 664 5,716 50.1%
2026-07-07 5,103 901 8,832 57.8%
2026-07-06 588 0 7,173 8.2%
2026-07-02 2,224 0 5,425 41.0%
2026-07-01 2,189 0 3,667 59.7%
2026-06-30 3,443 100 8,117 42.4%
2026-06-29 999 1 5,972 16.7%
2026-06-26 1,587 1 7,854 20.2%
2026-06-25 3,254 0 6,170 52.7%
2026-06-24 3,954 0 7,230 54.7%
2026-06-23 375 0 1,905 19.7%
2026-06-22 2,347 0 3,063 76.6%
2026-06-18 1,576 0 4,956 31.8%
2026-06-17 215 0 5,609 3.8%
2026-06-16 4,294 0 7,283 59.0%
2026-06-15 1,261 0 3,952 31.9%
2026-06-12 3,690 0 17,099 21.6%
2026-06-11 6,583 0 13,569 48.5%
2026-06-10 4,533 0 11,819 38.4%
2026-06-09 4,175 0 16,430 25.4%
2026-06-08 1,871 0 5,976 31.3%
2026-06-05 418 0 3,906 10.7%
2026-06-04 2,425 100 9,696 25.0%
2026-06-03 6,780 0 16,042 42.3%
2026-06-02 2,384 0 4,807 49.6%
2026-06-01 1,802 0 5,861 30.7%
2026-05-29 1,146 0 5,303 21.6%
2026-05-28 10,743 0 22,874 47.0%
2026-05-27 22,282 288 32,708 68.1%
2026-05-26 40,860 399 77,365 52.8%
2026-05-22 6,824 0 13,031 52.4%
2026-05-21 914 0 5,491 16.6%
2026-05-20 5,885 0 22,023 26.7%
2026-05-19 1,736 0 17,084 10.2%
2026-05-18 9,339 0 19,441 48.0%
2026-05-15 4,697 525 13,142 35.7%
2026-05-14 13,781 2,130 33,113 41.6%
2026-05-13 27,874 2,389 59,309 47.0%
Showing 1–50 of 62 days
Key facts CIK 1729427 CUSIP 18978H508 13F (30d) 1 filings 1 filers Visit website Investor relations